Natixis’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.47K | Buy |
+300
| New | +$3.47K | ﹤0.01% | 950 |
|
2023
Q2 | – | Sell |
-1,915
| Closed | -$107K | – | 1141 |
|
2023
Q1 | $107K | Sell |
1,915
-120
| -6% | -$6.7K | ﹤0.01% | 777 |
|
2022
Q4 | $74.2K | Buy |
+2,035
| New | +$74.2K | ﹤0.01% | 835 |
|
2022
Q2 | – | Sell |
-26,537
| Closed | -$2.02M | – | 1263 |
|
2022
Q1 | $2.02M | Sell |
26,537
-26,013
| -50% | -$1.98M | 0.01% | 749 |
|
2021
Q4 | $7.83M | Buy |
52,550
+11,158
| +27% | +$1.66M | 0.03% | 460 |
|
2021
Q3 | $6.03M | Buy |
+41,392
| New | +$6.03M | 0.02% | 497 |
|
2021
Q2 | – | Sell |
-46,152
| Closed | -$8.35M | – | 1053 |
|
2021
Q1 | $8.35M | Sell |
46,152
-74,854
| -62% | -$13.5M | 0.03% | 408 |
|
2020
Q4 | $17.1M | Buy |
+121,006
| New | +$17.1M | 0.06% | 285 |
|